Author: Lisa Green

Having attended ASCO’s 2021 Annual Meeting, Lisa Green reflects on the ideas of “right-sizing” therapy and artificial intelligence to help with clinical trial selection for oncology patients.

Broader inclusion of diverse populations in clinical trials has been a topic of conversation for several years, as there are significant disparities in representation of age, race, socio-economic status and gender in historical clinical trial design.  Now, the COVID pandemic has put an even greater public lens on how clinical trials are run and what populations are represented.